poorly soluble compounds
Identifying Formulations to Progress Compounds Solubility
March 20 by Niamh MadiganSolving solubility problems is one of the leading challenges in drug development, as poorly soluble compounds are estimated to account for 60% of compounds. Preclinical development encompasses the a...
Maximizing Bioavailability and Expediting Time-to-Market for Poorly Soluble Drug Candidates
February 02 by Pharma IQPoorly soluble candidates now account for 60 percent of drugs in the pipeline, and as technologies become more complex, the figure continues to increase. Pharmaceutical companies are now stepping...
Does Your Bioavailability Need a Boost?
March 29 by Pharma IQOne of the major drug development hurdles is poor solubility, an estimated 40 percent of drugs are poorly soluble or insoluble in water1. As a result, a number of companies and partne...
Improving Bioavailability with Novel Drug Delivery Solutions
December 22 by Andrea CharlesToxicology formulation is an essential component of drug development. Dr. Chong-Hui Gu, Associate Director at Vertex Pharmaceuticals, joins Andrea Charles from Pharma IQ, to discusss how&n...
